It has been shown that, in human breast cancer cells, PRL can activate sphingo-sine kinase-1 (SK-1) involved in apoptosis downregulation by catalyzing formation of sphingosine 1-phosphate (S1P) counteracting effects of ceramide [49,50]. The gene discussed is PRL; the disease is breast carcinoma.